SCANA Special Litigation Committee in nuclear facility investigation
We advised the committee following the abandonment of a multi-billion-dollar nuclear project
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Davis Polk Achieves Significant Appellate Victory for J.P. Morgan
Davis Polk is representing J.P. Morgan in a state securities fraud litigation pending in Florida state court. On Friday, June 9, 2017, we won a complete reversal of the trial court’s grant…
Davis Polk Victory in Facebook IPO Litigation
On November 3, 2016, the Second Circuit issued an opinion in an action brought under Section 16(b) of the Exchange Act of 1934 against Morgan Stanley, J.P. Morgan and Goldman Sachs, the…
Davis Polk Obtains Dismissal for Orexigen Directors in a Stock Compensation Derivative Litigation
Davis Polk represents several current and former directors of Orexigen Therapeutics (the “Company”) in connection with derivative litigation relating to the award of equity compensation. On…
Davis Polk Achieves Major Victory for Morgan Stanley in Section 10(b) Class Action Arising from Subprime Trading Losses
Davis Polk achieved a major victory on behalf of Morgan Stanley and certain of its officers and directors in a Section 10(b) shareholder class action arising from Morgan Stanley’s 2007…
Major Victory for Morgan Stanley in ERISA Class Actions Arising from $9 Billion in Trading Losses and the Financial Crisis
Davis Polk achieved a major victory on behalf of Morgan Stanley and certain of its officers and directors in two Employee Retirement Income Security Act of 1974 (“ERISA”) class actions…